EUVIMEDEUVIMED entdecken
Crossref

Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle

Le Tu, Chonglu Li, Qihang Ding, Amit Sharma iD, Meiqin Li, Junrong Li iD, Jong Seung Kim iD, Yao Sun iD

Journal of the American Chemical Society · 2024

DOI: 10.1021/jacs.3c13224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Le Tu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry…. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Science and Engineering Research Board, National Research Foundation of Korea, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumAntineoplastic AgentsNeoplasmsHumansReactive Oxygen SpeciesImmunogenic Cell DeathLysosomesCell Line, Tumor

Substanzen

RutheniumReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, China.
  • State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, China.
  • Department of Chemistry, Korea University, Seoul 02841, Korea.
  • Amity School of Chemical Sciences, Amity University Punjab, Sector 82A, Mohali, Punjab 140306, India.

ORCID-Profile: Amit Sharma, Junrong Li, Jong Seung Kim, Yao Sun

Förderung

  • Science and Engineering Research Board
  • National Research Foundation of Korea
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Natural Science Foundation of Hubei Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Tu, L., Li, C., Ding, Q., Sharma, A., Li, M., Li, J., Kim, J. S., & Sun, Y. (2024). Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c13224

Vancouver

Tu L, Li C, Ding Q, Sharma A, Li M, Li J, et al. Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.3c13224

BibTeX
@article{Tu2024,
  author = {Tu, Le and Li, Chonglu and Ding, Qihang and Sharma, Amit and Li, Meiqin and Li, Junrong and Kim, Jong Seung and Sun, Yao},
  title = {Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  doi = {10.1021/jacs.3c13224}
}
Kostenlos starten →